Biological Age Testing
Epigenetic clocks work by reading DNA methylation marks — chemical tags on the genome that accumulate in predictable patterns as we age. Unlike a standard blood panel, these clocks synthesize thousands of methylation sites into a single age estimate that outperforms almost every other biomarker for predicting mortality, disease onset, and functional decline. Different clocks measure different things: some estimate where your biology sits today, others measure the pace at which you are accumulating biological aging from one year to the next. Understanding which clock answers which question determines which test is worth your money.
DNA methylation refers to the addition of a methyl group to cytosine bases in your genome. These marks change in characteristic patterns as you age, and machine learning models trained on thousands of samples can now read those patterns to estimate biological age with remarkable accuracy. The core insight: your epigenome records your cumulative lifestyle exposures — sleep, diet, stress, exercise, smoking — in a way that your genome does not.
Why it matters for longevity: a biological age that runs younger than your chronological age correlates strongly with lower all-cause mortality, reduced cardiovascular risk, and preserved cognitive function. Crucially, methylation clocks are responsive to intervention — meaning you can test, change a behavior, retest, and see a measurable shift within months. That feedback loop is what makes them clinically actionable in a way that genetics alone is not.
Educational ranking only. Not medical advice. Evidence grade refers to published human research on this ingredient — not proof that any specific product treats or prevents disease. Affiliate links may generate revenue but never affect ratings.
TruDiagnostic TruAge Complete
TruAge Complete is the most clinically dense consumer epigenetic test available. It reports multiple validated clocks simultaneously — Horvath ↗, PhenoAge, GrimAge, and DunedinPACE — as well as organ-system biological ages and telomere length estimated from the same blood sample. The inclusion of DunedinPACE is the key differentiator: while other clocks estimate your current biological age, DunedinPACE estimates the rate at which you are aging (expressed as years of biological aging per calendar year). A score of 0.85 means you are aging at 85% of the average rate; a score of 1.15 means 15% faster than average. DunedinPACE was derived from the Dunedin longitudinal cohort (n=954) and has been validated in multiple independent cohorts as the most intervention-responsive epigenetic metric currently available (Belsky et al., 2022, eLife). For tracking whether lifestyle changes are actually working, this is the EBL founder's recommended starting point.
Elysium Index
Elysium Index is the only consumer product that independently reports biological ages for 19 separate organ systems — heart, brain, immune, kidney, liver, metabolic, and more — all derived from a single blood-based DNA methylation assay. The methodology builds on the tissue-specific clock frameworks established by Horvath and colleagues, trained on tissue-matched methylation data so each organ clock reflects the aging trajectory of that specific system rather than whole-blood average aging. This level of resolution is not available from any other direct-to-consumer test. The trade-off is cost (~$499) and a narrower intervention-tracking use case: because the organ clocks do not include DunedinPACE, they are less sensitive to short-term lifestyle changes than TruDiagnostic's panel. Most useful as a one-time deep-dive baseline, especially if you have a family history of failure in a specific organ system (e.g., cardiovascular or renal disease).
GRAIL Galleri
Galleri uses a different application of cell-free DNA methylation analysis: instead of estimating biological age, it screens for circulating cancer DNA from 50+ cancer types in a single blood draw. The test looks for aberrant methylation signatures characteristic of tumor-derived DNA and, when a signal is detected, uses the methylation pattern to predict the tissue of origin. In the PATHFINDER study (Schrag et al., 2023, The Lancet, n=6,621), the positive predictive value was 38% and cancer signal was detected before symptoms in a meaningful proportion of cases. Kohler et al. (2021, Annals of Oncology) reported detection sensitivity of approximately 67% across 50 cancer types at high specificity. Included here for completeness because it is technically an epigenetic blood test — but the use case is cancer surveillance, not aging optimization. Requires a physician order and is not covered by most insurance at ~$949.
One research-grounded briefing per week. No hype, no affiliate push, no AI-generated filler.
Educational ranking only. Not medical advice. Evidence grade refers to published human research on this ingredient — not proof that any specific product treats or prevents disease. Affiliate links may generate revenue but never affect ratings.
Phase Angle: The Body Composition Metric That Actually Predicts Mortality
Most body composition metrics tell you how much fat or muscle you have. Phase angle tells you something more fundamental: the electrical integrity of your cells. It is the single body composition output with the strongest independent association with mortality in the published literature — and it is largely unknown outside clinical settings.
Bioelectrical impedance analysis (BIA) sends a small electrical current through the body. Phase angle is the ratio of reactance to resistance in that signal — a direct measure of how much the cell membranes resist versus delay the current. Healthy cell membranes with intact lipid bilayers produce a higher phase angle. Damaged, dehydrated, or aging cells produce a lower one.
Unlike calculated outputs (fat mass, muscle mass), phase angle is a raw electrical measurement. It does not depend on population-specific equations, which is why it holds up across body types and demographics where other BIA metrics drift.
In the NHANES cohort, older adults in the lowest phase angle quintile had a 3x higher risk of frailty and significantly elevated long-term mortality — independent of age, sex, race, BMI, and comorbidity. In a separate cohort of 1,307 adults over 65, low phase angle predicted mortality over a 10-year follow-up period regardless of other clinical variables. (Gonzalez et al., Reviews in Endocrine & Metabolic Disorders, 2022)
Seven of eight published studies found significantly lower phase angle values in sarcopenic vs. non-sarcopenic older adults. Phase angle predicted falls in a 2-year follow-up period in older adults with rheumatoid arthritis, while standard sarcopenia criteria did not. Every 1-degree increment in phase angle over one year was associated with a 4x higher likelihood of improving from a frail to a pre-frail state. (Di Vincenzo et al., 2022)
Phase angle rises with resistance training in older adults and responds to nutritional repletion — particularly protein and creatine. This makes it a trackable metric: establish a baseline, apply a protocol (resistance training, creatine, adequate protein), retest at 90 days. Unlike epigenetic clocks ($300–$400 per test), repeat phase angle measurements cost nothing beyond access to the device.
Phase angle norms are age- and sex-specific. Broadly: values above 6° are generally favorable in adults; values above 7° are associated with athletic or well-trained populations; values below 4.5° in older adults signal elevated risk. The trend over time matters more than a single reading. A rising phase angle across quarterly measurements is a meaningful signal that cellular health is improving.
Phase angle is produced by clinical-grade InBody devices (InBody 570, 770, 970) and equivalent professional BIA units. Consumer body composition scales do not report it. This means tracking phase angle requires access to a clinician, longevity practice, gym, or medical facility that has the equipment. It is not a DIY metric — but if your clinician has the device, it is worth requesting at every visit and tracking the number over time.
- Free to repeat (if device is available)
- Measures cellular membrane integrity directly
- Results in 45 seconds
- Strong mortality prediction data
- Responds to creatine, protein, resistance training
- Requires clinical-grade BIA device
- $300–$400 per test
- Measures DNA methylation patterns
- Results in 2–4 weeks
- Strong all-cause mortality and disease risk data
- DunedinPACE most intervention-responsive
- At-home blood spot or blood draw
These are complementary, not competing. Epigenetic clocks measure aging at the gene expression level; phase angle measures cellular health at the membrane level. Using both gives a more complete picture than either alone.